Our studies of MDMs suggest that some of these are M1-polarized MΦ, but based on CD68, CD80, CD163, and CD206, which are typically used for MΦ polarization, it is apparent that tumor-associated MΦ subsets occupy a broad spectrum within this classification. The gene discussed is CD80; the disease is neoplasm.